Insulin action enhancement normalizes brachial artery vasoactivity in patients with peripheral vascular disease and occult diabetes
- 1 December 1998
- journal article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 28 (6) , 1024-1032
- https://doi.org/10.1016/s0741-5214(98)70028-x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levelsPublished by Elsevier ,2004
- Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling.Journal of Clinical Investigation, 1997
- Transforming growth factor β1 inhibits the proliferative effect of insulin on human infragenicular vascular smooth muscle cellsJournal of Vascular Surgery, 1997
- Impaired Glucose Tolerance is Normalized by Treatment With the Thiazolidinedione TroglitazoneDiabetes Care, 1997
- Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitusJournal of the American College of Cardiology, 1996
- Vascular reactivity in patients with peripheral vascular diseaseThe American Journal of Cardiology, 1995
- Nitric oxide release accounts for insulin's vascular effects in humans.Journal of Clinical Investigation, 1994
- Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosisJournal of the American College of Cardiology, 1994
- Insulin and Atheroma: 20-Yr PerspectiveDiabetes Care, 1990
- International Criteria for the Diagnosis of Diabetes and Impaired Glucose ToleranceDiabetes Care, 1985